Medicamen Organics Limited (NSE:MEDIORG)
India · Delayed Price · Currency is INR 23.65
+1.10 (4.88%)
Jan 23, 2026, 3:01 PM IST
Medicamen Organics Revenue
Medicamen Organics had revenue of 178.52M INR in the half year ending September 30, 2025, with 57.71% growth. This brings the company's revenue in the last twelve months to 394.30M, up 28.01% year-over-year. In the fiscal year ending March 31, 2025, Medicamen Organics had annual revenue of 381.88M with 51.11% growth.
Revenue (ttm)
394.30M
Revenue Growth
+28.01%
P/S Ratio
0.70
Revenue / Employee
3.46M
Employees
114
Market Cap
276.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 381.88M | 129.16M | 51.11% |
| Mar 31, 2024 | 252.72M | 31.25M | 14.11% |
| Mar 31, 2023 | 221.47M | 11.72M | 5.59% |
| Mar 31, 2022 | 209.75M | -40.72M | -16.26% |
| Mar 31, 2021 | 250.47M | -64.39M | -20.45% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Add-Shop E-Retail | 1.46B |
| ANG Lifesciences India | 922.09M |
| Deccan Health Care | 847.12M |
| JFL Life Sciences | 744.78M |
| Sandu Pharmaceuticals | 667.62M |
| Gujarat Terce Laboratories | 501.95M |
| Panjon | 463.51M |
| Vilin Bio Med | 199.81M |